Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The aims of this study are to prospectively evaluate the efficacy of two intravenous
infusions of pamidronate 90 mg, associated with calcium and calcidiol, in the early
post-transplant period, on bone loss in liver transplant recipients, and to asses the safety
of this treatment.